These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31327506)

  • 1. Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysis.
    Krause M; Gutsmiedl K; Bighelli I; Schneider-Thoma J; Chaimani A; Leucht S
    Eur Neuropsychopharmacol; 2019 Sep; 29(9):1003-1022. PubMed ID: 31327506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis.
    Zhou X; Cipriani A; Zhang Y; Cuijpers P; Hetrick SE; Weisz JR; Pu J; Del Giovane C; Furukawa TA; Barth J; Coghill D; Leucht S; Yang L; Ravindran AV; Xie P
    BMJ Open; 2017 Aug; 7(8):e016608. PubMed ID: 28801423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.
    Zhou X; Teng T; Zhang Y; Del Giovane C; Furukawa TA; Weisz JR; Li X; Cuijpers P; Coghill D; Xiang Y; Hetrick SE; Leucht S; Qin M; Barth J; Ravindran AV; Yang L; Curry J; Fan L; Silva SG; Cipriani A; Xie P
    Lancet Psychiatry; 2020 Jul; 7(7):581-601. PubMed ID: 32563306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials.
    Kong W; Deng H; Wan J; Zhou Y; Zhou Y; Song B; Wang X
    Front Pharmacol; 2020; 11():580858. PubMed ID: 33343351
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative efficacy and acceptability of interventions for major depression in older persons: protocol for Bayesian network meta-analysis.
    Liew TM; Lee CS
    BMJ Open; 2018 Jan; 8(1):e019819. PubMed ID: 29358451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of nonpharmacological interventions in older adults with depressive disorders: a systematic review.
    Apóstolo J; Queirós P; Rodrigues M; Castro I; Cardoso D
    JBI Database System Rev Implement Rep; 2015 Jul; 13(6):220-78. PubMed ID: 26455753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol.
    Doyle F; Freedland K; Carney R; de Jonge P; Dickens C; Pedersen S; Sorensen J; Dempster M
    Syst Rev; 2019 Mar; 8(1):71. PubMed ID: 30878039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
    De Giorgi R; De Crescenzo F; Rizzo Pesci N; Martens M; Howard W; Cowen PJ; Harmer CJ
    PLoS One; 2021; 16(3):e0249409. PubMed ID: 33784356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis.
    Kishi T; Sakuma K; Hatano M; Okumura T; Kato M; Baba H; Iwata N
    Neuropsychopharmacol Rep; 2024 Mar; 44(1):267-271. PubMed ID: 38318955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
    Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
    CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
    Kishi T; Matsunaga S; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):149-161. PubMed ID: 27318835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis.
    Chen C; Shan W
    Psychiatry Res; 2019 Nov; 281():112595. PubMed ID: 31627074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.